Synapse - Works

Results (13087)

Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer

Meeting Abstract

Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S.; Ladle, B. H.; Noujaim, J.; He, K.; Liebner, D.; Sacher, A. G.; Haanen, J. B. A. G.; more...
Cancer Research (2021)

Fulltext@MSK | Save

Addition of parsaclisib (INCB050465), a PI3Kδ inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis

Meeting Abstract

Yacoub, A.; Wang, E. S.; Rampal, R. K.; Borate, U.; Kremyanskaya, M.; Ali, H.; Hobbs, G. S.; O'Connell, C.; Assad, A.; Erickson-Viitanen, S.; more...
Cancer Research (2021)

Fulltext@MSK | Save

HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring

Meeting Abstract

Li, L.; Kim, J. H.; Lu, W.; Williams, D. M.; Xian, L.; Kim, J.; Rogers, O.; Rampal, R. K.; Koche, R. P.; Cope, L.; more...
Cancer Research (2021)

Fulltext@MSK | Save

A phase 2, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumors

Meeting Abstract

Gettinger, S.; Kluger, H.; Schoenfeld, A.; Betof-Warner, A.; He, K.; Sukari, A.; de Speville Uribe, B. D.; Lee, S.; Haefliger, S.; Goldberg, Z.; more...
Cancer Research (2021)

Fulltext@MSK | Save

Kinetics of radiographic response for tebentafusp (tebe) in previously treated metastatic uveal melanoma (mUM) patients (pts) achieving prolonged survival

Meeting Abstract

Butler, M. O.; Sato, T.; Carvajal, R. D.; Sacco, J. J.; Abdullah, S. E.; Holland, C.; Goodall, H.; Shoushtari, A. N.
Cancer Research (2021)

Fulltext@MSK | Save

Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung

Meeting Abstract

Concepcion, C. P.; Ma, S.; LaFave, L. M.; Bhutkar, A.; Liu, M.; DeAngelo, L. P.; Kim, J. Y.; Del Priore, I.; Schoenfeld, A. J.; Kartha, V. K.; more...
Cancer Research (2021)

Fulltext@MSK | Save

Tebentafusp induces transient systemic inflammation and modifies the micro-environment to sensitize uveal melanoma tumors to cytotoxic CD8 cells

Meeting Abstract

Butler, M. O.; Stanhope, S.; Naidoo, R.; Leach, E.; Kaur, S.; Collins, L.; Abdullah, S.; Ranade, K.; Shoushtari, A. N.
Cancer Research (2021)

Fulltext@MSK | Save

PRMT5 inhibition regulates alternative splicing and DNA damage repair pathways in SF3B1 R625G expressing uveal melanoma cells

Meeting Abstract

Ito, K.; Thodima, V.; Carter, J.; Bhagwat, N.; Sivakumar, M.; Grego, A.; Rager, J.; Terai, M.; Sato, T.; Abdel-Wahab, O.; more...
Cancer Research (2021)

Fulltext@MSK | Save

ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy

Meeting Abstract

D'Angelo, S.; Robinson, S.; Lam, J.; Adams, B.; Freddo, J.; Theuer, C. P.; Maki, R.
Cancer Research (2021)

Fulltext@MSK | Save

MYC promotes tyrosine kinase inhibitor resistance in ROS1 fusion positive lung cancers

Meeting Abstract

Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Sato, H.; Siau, E.; Drilon, A.; Riely, G. J.; Somwar, R.; Ladanyi, M.; Davare, M. A.
Cancer Research (2021)

Fulltext@MSK | Save